Skip to main content
European Commission logo print header

Prognostic value of upar forms in colon and breast cancer

Objectif

Investigation of the clinical prognostic value of soluble urokinase plasminogen activator receptor (uPAR) forms in blood and tissue extracts from patients with colon and breast cancer, aiming to develop new methods which will aid in the decision-making needed in the management of cancer patients.

Appel à propositions

Data not available

Coordinateur

COPENHAGEN UNIVERSITY HOSPITAL
Contribution de l’UE
Aucune donnée
Adresse
Stransboulevarden 49
2100 KOEPENHAGEN
Danemark

Voir sur la carte

Coût total
Aucune donnée